Cannabis Law Report
JANUARY 10, 2022
This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.
Canna Care Docs
DECEMBER 16, 2020
The evidence of its effectiveness is clear, as clinical trials have shown a significant reduction in pain for patients suffering with neuropathic pain from multiple sclerosis, pain from rheumatoid arthritis, cancer pain, HIV or complex regional pain syndrome, headaches and menstrual pain, among other potential uses. Chronic pain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 24, 2019
T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. 2014): 86-95. Epilepsy & behavior case reports 9 (2018): 10. Drug metabolism reviews 46.1 Alsherbiny, Muhammad, and Chun Li. Medicines 6.1
CannaMD
AUGUST 8, 2020
Fortunately in 2014, the Federal Farm Bill re-opened the door for industrial hemp research. Designed to treat seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome , Epidiolex is a purified (> 98% oil-based) CBD extract administered via oral spray. In 1970, the U.S.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. 2014): 86-95. [2] Epilepsy & behavior case reports 9 (2018): 10. [4] Drug metabolism reviews 46.1 2] Alsherbiny, Muhammad, and Chun Li. Medicines 6.1
Cannabis Law Report
JUNE 1, 2021
Director of Medical Affairs and a Product Development Team lead at Greenwich Biosciences, where he played an important role in the complex, successful commercialization of the first cannabis-based product approved by the FDA to treat rare forms of epilepsy.
Expert insights. Personalized for you.
52 
Let's personalize your content